A researcher at the University of California, Los Angeles Jonsson Comprehensive Cancer Center has helped develop a combination drug therapy that shows promise in extending the lives of people with metastatic melanoma. The new therapy also accomplishes this result without the side effect of a secondary skin cancer seen in some patients prescribed only one… Continue reading New Melanoma Combo Therapy Improves Survival Rate